Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amit Garg

Showing results (241-250 of 352) with videos related to

Pageof 36
Sort By:
BMJ Open|February 19, 2020
Impact of the KidneyWise toolkit on chronic kidney disease referral practices in Ontario primary care: a prospective evaluationKenneth Scott Brimble, Philip Boll, Allan K Grill, et al.
American Journal of Clinical Dermatology|June 28, 2023
Disease Burden and Treatment Patterns Among US Patients with Hidradenitis Suppurativa: A Retrospective Cohort StudyAmit Garg, Yvonne Geissbühler, Emma Houchen, et al.
Dermatology (Basel, Switzerland)|May 22, 2019
Patient-Reported Outcome Measures for Pediatric Psoriasis: A Systematic Review and Critical Appraisal from International Dermatology Outcome Measures (IDEOM)Nicole Salame, Josefina Torres, Jeena Sandhu, et al.
Health Economics|September 17, 2019
Production of physician services under fee-for-service and blended fee-for-service: Evidence from Ontario, CanadaNibene H Somé, Rose Anne Devlin, Nirav Mehta, et al.
Cancer Chemotherapy and Pharmacology|September 4, 2013
Exposure-response analysis of pertuzumab in HER2-positive metastatic breast cancer: absence of effect on QTc prolongation and other ECG parametersAmit Garg, Jing Li, Emma Clark, et al.
JAMA Dermatology|January 10, 2024
Factors Affecting Treatment Selection Among Patients With Hidradenitis SuppurativaNicole Salame, Yacine N Sow, Meron R Siira, et al.
American Journal of Clinical Dermatology|May 14, 2025
Correction to: Disease Burden and Treatment Patterns Among US Patients with Hidradenitis Suppurativa: A Retrospective Cohort StudyAmit Garg, Yvonne Geissbühler, Emma Houchen, et al.
The Journal of Rheumatology|November 3, 2012
Exploring priority research areas in psoriasis and psoriatic arthritis from dermatologists' perspective: a report from the GRAPPA 2011 annual meetingApril W Armstrong, Kristina Callis Duffin, Amit Garg, et al.
The British Journal of Dermatology|May 23, 2022
Development and initial validation of the HS-IGA: a novel hidradenitis suppurativa-specific investigator global assessment for use in interventional trialsAmit Garg, Carla Zema, Katherine Kim, et al.
Cancer Chemotherapy and Pharmacology|August 15, 2014
Population pharmacokinetic and covariate analysis of pertuzumab, a HER2-targeted monoclonal antibody, and evaluation of a fixed, non-weight-based dose in patients with a variety of solid tumorsAmit Garg, Angelica Quartino, Jing Li, et al.
Pageof 36

Showing results (241-250 of 352) with videos related to

Sort By:
Pageof 36
BMJ Open|February 19, 2020
Impact of the KidneyWise toolkit on chronic kidney disease referral practices in Ontario primary care: a prospective evaluationKenneth Scott Brimble, Philip Boll, Allan K Grill, et al.
American Journal of Clinical Dermatology|June 28, 2023
Disease Burden and Treatment Patterns Among US Patients with Hidradenitis Suppurativa: A Retrospective Cohort StudyAmit Garg, Yvonne Geissbühler, Emma Houchen, et al.
Dermatology (Basel, Switzerland)|May 22, 2019
Patient-Reported Outcome Measures for Pediatric Psoriasis: A Systematic Review and Critical Appraisal from International Dermatology Outcome Measures (IDEOM)Nicole Salame, Josefina Torres, Jeena Sandhu, et al.
Health Economics|September 17, 2019
Production of physician services under fee-for-service and blended fee-for-service: Evidence from Ontario, CanadaNibene H Somé, Rose Anne Devlin, Nirav Mehta, et al.
Cancer Chemotherapy and Pharmacology|September 4, 2013
Exposure-response analysis of pertuzumab in HER2-positive metastatic breast cancer: absence of effect on QTc prolongation and other ECG parametersAmit Garg, Jing Li, Emma Clark, et al.
JAMA Dermatology|January 10, 2024
Factors Affecting Treatment Selection Among Patients With Hidradenitis SuppurativaNicole Salame, Yacine N Sow, Meron R Siira, et al.
American Journal of Clinical Dermatology|May 14, 2025
Correction to: Disease Burden and Treatment Patterns Among US Patients with Hidradenitis Suppurativa: A Retrospective Cohort StudyAmit Garg, Yvonne Geissbühler, Emma Houchen, et al.
The Journal of Rheumatology|November 3, 2012
Exploring priority research areas in psoriasis and psoriatic arthritis from dermatologists' perspective: a report from the GRAPPA 2011 annual meetingApril W Armstrong, Kristina Callis Duffin, Amit Garg, et al.
The British Journal of Dermatology|May 23, 2022
Development and initial validation of the HS-IGA: a novel hidradenitis suppurativa-specific investigator global assessment for use in interventional trialsAmit Garg, Carla Zema, Katherine Kim, et al.
Cancer Chemotherapy and Pharmacology|August 15, 2014
Population pharmacokinetic and covariate analysis of pertuzumab, a HER2-targeted monoclonal antibody, and evaluation of a fixed, non-weight-based dose in patients with a variety of solid tumorsAmit Garg, Angelica Quartino, Jing Li, et al.
Pageof 36